Gabapentin Tablet, Film Coated
Product Images NDC 55154-8193

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 55154-8193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ahp50701

Ahp50701
FDA Label Image

Ahp51801

Ahp51801
FDA Label Image

Equation

Equation
FDA Label Image

Figure 1

Figure 1
It appears to be a chart or graph displaying mean pain scores for a 4-week dose titration period and a 4-week fixed dose period, consisting of a placebo and Gabapentin dosage of 3600mg/day. The baseline and week 1 are also indicated. There is not enough context to determine further information.*
FDA Label Image

Figure 2

Figure 2
FDA Label Image

Figure 3

Figure 3
This appears to be a chart showing percentages and monetary values for a study. Additionally, there may be a significant finding represented by "*p<0001." However, without further context or information, it is difficult to provide a more accurate description.*
FDA Label Image

Figure 4

Figure 4
FDA Label Image

Structure

Structure
FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Gabapentin Tablets USP of 600mg dosage containing 10 tablets per package. Each tablet is film-coated and includes 500mg of Gabapentin USP. The usual dosage of the medication should be as directed by a doctor. The storage requirement of the drug is between 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C to 30°C (59°F to 86°F). The package is not child-resistant and should be kept out of children's reach. Pharmaceuticals containing Gabapentin USP of NDC # 63382-204 are packaged and distributed by American Health Packaging. Pharmacies should dispense the drug with the medication guide, and the blister should not be used if it is torn or broken.*
FDA Label Image

Bag Label (Image 02)

Bag Label (Image 02)
This is a medication package containing 10 tablets of Gabapentin, each film-coated tablet containing 800 mg of Gabapentin USP. The usual dosage and precautions are stated to be found in the product insert. The Package is not child-resistant and is intended for institutional use only. Pharmacist Instructions are provided to dispense this medication with medication guide to each patient. The drug product is contained in a blister package, identified by the NDC number 52382-205, and manufactured by Zydus Pharmaceuticals Inc, and packaged and distributed by American Health Packaging, an AmerisourceBergen company, located in Columbus, Ohio. Distributed by Cardinal Health in Dublin, Ohio. Storage conditions and handling instructions are provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.